Panel. Modernising payment models for CGTs

Описание: Sponsored by Johnson & Johnson
The cost of CGTs is immense, ranging from the hundreds of thousands of dollars to the millions for each patient. To enlarge the population eligible for treatment, a change is needed. How can payment structures keep pace with science? How effective are innovative approaches such as models based on performance or outcomes, which share risk between the payer, provider and manufacturer? How can novel financial approaches be developed to keep the costs of CGTs from being prohibitive for patients? How can stakeholders and policymakers work together to support affordability?